The fatty acid amide hydrolase (FAAH) Pro129Thr polymorphism is not associated with severe obesity in Greek subjects

Hormone and Metabolic Research

Volumn 40, Issue 12, 2008, Pages 907-910

  Papazoglou, D ^a,d   Panagopoulos, I ^b   Papanas, N ^a   Gioka, T ^c   Papadopoulos, T ^a   Papathanasiou, P ^a   Kaitozis, O ^a   Papatheodorou, K ^a   Maltezos, E ^a  

^a DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c DEMOCRITUS UNIVERSITY OF THRACE   (Greece)

^d NONE   (Greece)

Author keywords

Association study; Endocannabinoid system; Genetics; Metabolic syndrome; SNP

Indexed keywords

FATTY ACID AMIDASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN;

ADULT; AMINO ACID SUBSTITUTION; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GREECE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL;

ADULT; AGED; AMIDOHYDROLASES; AMINO ACID SUBSTITUTION; ANTHROPOMETRY; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; FEMALE; GENOTYPE; GREECE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; POLYMORPHISM, GENETIC; RISK;

EID: 58149105389     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1087169     Document Type: Article

References (20)

1. Yanovski SZ, Yanovski JA. Obesity. N Engl J Med 2002; 346: 591-602
2. Schwarz PE, Reimann M, Li J, Bergmann A, Licinio J, Wong ML, Bornstein SR. The Metabolic syndrome - a global challenge for prevention. Horm Metab Res 2007; 39: 777-780
3. Barsh GS, Farooqi IS, O'Rahilly S. Genetics of body-weight regulation. Nature 2000; 404: 644-651
4. Jamshidi N, Taylor DA. Anandamide administration into the ventro-medial hypothalamus stimulates appetite in rats. Br J Pharmacol 2001; 134: 1151-1154
5. Williams CM, Kirkham TC. Observational analysis of feeding induced by Delta9-THC and anandamide. Physiol Behav 2002; 76: 241-250
6. Cota D, Marsicano G, Lutz B, Vicennati V, Stalla GK, Pasquali R, Pagotto U. Endogenous cannabinoid system as a modulator of food intake. Int J Obes Relat Metab Disord 2003; 27: 289-301
7. Fagotto U, Marsicano G, Cota D, Lutz B, Pasquali R. The emerging role of the endonnabinoid system in endocrine regulation and energy balance. Endocr Rev 2006; 27: 73-100
8. Kempf K, Hector J, Strate T, Schwarzloh B, Rose B, Herder C, Martin S, Algenstaedt P. Immune-mediated activation of the endocannabinoid system in visceral adipose tissue in obesity. Horm Metab Res 2007; 39: 596-600
9. Cravatt BF, Giang DK, Mayfield SM, Boger DL, Lerner RA, Gilula NB. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature 1996; 384: 83-87
10. Kurahashi Y, Ueda N, Suzuki H, Suzuki M, Yamamoto S. Reversible hydrolysis and synthesis of anandamide demonstrated by recombinant rat fatty-acid amide hydrolase. Biochem Biophys Res Commun 1997; 237: 512-515
11. Giang DK, Cravatt BF. Molecular characterization of human and mouse fatty acid amide hydrolases. Proc Natl Acad Sci USA 1997; 94: 2238-2242
12. Sipe JC, Chiang K, Gerber AL, Beutler E, Cravatt BF. A missense mutation in human fatty acid amide hydrolase associated with problem drug use. Proc Natl Acad Sci USA 2002; 99: 8394-8399
13. Chiang KP, Gerber AL, Sipe JC, Cravatt BF. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum Mol Genet 2004; 13: 2113-2119
14. Sipe JC, Waalen J, Gerber A, Beutler E. Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH). Int J Obes 2005; 29: 755-759
15. Jensen DP, Andreasen CH, Andersen MK, Hansen L, Eiberg H, Borch-Johnsen K, Jorgensen T, Hansen T, Pedersen O. The functional Pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5,801 whites. J Mol Med 2007; 85: 445-449
16. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association. National Heart, Lung, and Blood Institute. Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive Summary. Circulation 2005; 112: e285-e290
17. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. Hypertension 2003; 42: 1206-1252
18. Price RA, Lee JH. Risk ratios for obesity in families of obese African-American and Caucasian women. Hum Hered 2001; 15: 135-140
19. Drenick EJ, Bale GS, Seltzer F, Johnson DG. Excessive mortality and causes of death in morbidly obese men. JAMA 1980; 243: 443-445
20. Aberle J, Fedderwitz I, Klages N, George E, Beil FU. Genetic variation in two proteins of the endocannabinoid system and their influence on body mass index and metabolism under low fat diet. Horm Metab Res 2007; 39: 395-397